ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Psychiatry

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,941Medicare Part D Prescriptions Filled, Including Refills

Rank: 4 out of 347

$821K Total Retail Price of All Prescriptions

Rank: 4 out of 347

467 Patients Receiving at Least One Drug in Part D
50%Patients 65 Years and Older
77% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Virginia
Lower avg

Schedule Two
Controlled Substances

11% of this provider’s 467 patients filled at least one prescription for a schedule two drug, compared to an average of 2%.

Schedule Three
Controlled Substances

3% of this provider’s 467 patients filled at least one prescription for a schedule three drug, compared to an average of 0%.

Risky Drugs to Seniors

7% of this provider’s 2,997 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 3%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$103 was the average price of a prescription from this provider, compared to $113 among peers.

Prescriptions per Patient

17 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Virginia
BENZTROPINE MESYLATE 435 123 R 1 3
QUETIAPINE FUMARATE 373 152 2 4
RISPERIDONE 355 124 3 1
TRAZODONE HCL 348 135 4 2
CITALOPRAM HBR 281 119 5 6
NAMENDA 236 206 6 39
HALOPERIDOL 226 61 7 15
CYMBALTA 203 80 8 11
VENLAFAXINE HCL ER 198 83 9 19
MIRTAZAPINE 196 104 10 18
FLUOXETINE HCL 196 88 10 9
ZOLPIDEM TARTRATE 177 56 12 17
OLANZAPINE 169 59 13 8
DONEPEZIL HCL 157 140 14 34
BUPROPION HCL SR 150 53 15 20
SERTRALINE HCL 137 47 16 5
OXCARBAZEPINE 135 34 17 37
GABAPENTIN 134 45 18 23
DIVALPROEX SODIUM 133 39 19 16
ABILIFY 124 29 20 7
TRAMADOL HCL 114 80 21 95
LAMOTRIGINE 113 0 22 13
LEVOTHYROXINE SODIUM 110 69 23 36
METHYLPHENIDATE HCL 107 31 24 53
DIVALPROEX SODIUM ER 103 18 25 14
AMPHETAMINE SALT COMBO 102 0 S2 26 31
SEROQUEL 102 50 26 26
LITHIUM CARBONATE 99 0 28 10
ZIPRASIDONE HCL 98 26 29 30
TOPIRAMATE 92 0 30 27
THIOTHIXENE 86 59 31 46
HYDROXYZINE PAMOATE 84 37 R 32 28
ALPRAZOLAM 84 36 32 55
SEROQUEL XR 83 12 34 32
CLOZAPINE 79 0 35 12
AMITRIPTYLINE HCL 74 36 R 36 50
ESCITALOPRAM OXALATE 67 37 37 25
BUPROPION XL 58 0 38 21
TRIFLUOPERAZINE HCL 57 40 39 98
CLONIDINE HCL 54 0 40 74
HALOPERIDOL DECANOATE 54 12 40 33
FLUVOXAMINE MALEATE 52 24 42 40
PROPRANOLOL HCL 51 0 43 51
BUSPIRONE HCL 51 0 43 24
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 29, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.